Jazz PLC Rule 144: Two 6,000-Share Sales Reported

Jazz Pharmaceuticals (Rule 144 notice): The filing reports sales of restricted common stock in lots of 6,000 shares.

Rhea-AI Filing Summary

Jazz Pharmaceuticals (Rule 144 notice): The filing reports sales of restricted common stock in lots of 6,000 shares. Two sale entries are shown with trade dates 03/03/2026 and 04/01/2026, each for 6,000 shares, with numeric amounts listed alongside those rows.

Insights

Securities Compliance Counsel

Rule 144 notice of sale of restricted Jazz common stock; routine disclosure.

The filing lists two transactions of 6,000 shares each with trade dates of 03/03/2026 and 04/01/2026

These entries appear to be routine Rule 144 filings notifying the market of restricted-stock sales. No additional qualifiers or issuer‑proceeds statements are present in the excerpt; subsequent filings would show settlement or reporting details.

Key Figures

Shares sold (entry 1): 6,000 shares Shares sold (entry 2): 6,000 shares Numeric amount adjacent (entry 1): 1,143,010.3 +1 more

4 metrics

Shares sold (entry 1) 6,000 shares trade date <date>03/03/2026</date>

Shares sold (entry 2) 6,000 shares trade date <date>04/01/2026</date>

Numeric amount adjacent (entry 1) 1,143,010.3 number listed alongside the 6,000-share row dated <date>04/01/2026</date>

Numeric amount adjacent (entry 2) 1,118,613.32 number listed alongside the 6,000-share row dated <date>03/03/2026</date>

Key Terms

Rule 144, restricted stock, stock option, Merrill Lynch

4 terms

Rule 144 regulatory

"144: Securities To Be Sold"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock financial

"144: Securities Sold During The Past 3 Months"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

stock option financial

"Stock Option | Jazz Pharmaceuticals PLC"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Merrill Lynch market

"Merrill Lynch 3075A Hansen Way 1st Floor Palo Alto"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the JAZZ Rule 144 filing report?

It reports two sales of restricted Jazz common stock, each for 6,000 shares. The entries include trade dates 03/03/2026 and 04/01/2026 and numeric amounts listed alongside those rows in the excerpt.

Who is the seller named in the JAZZ 144 excerpt?

The excerpt names Bruce Cozadd at an address in Dublin as the reporting holder. The rows list Bruce Cozadd with associated sale dates and share counts of 6,000 shares per entry.

How many Jazz (JAZZ) shares are shown as sold in the excerpt?

The excerpt shows two separate transactions of 6,000 shares each, totaling 12,000 shares shown. Trade dates are 03/03/2026 and 04/01/2026 in the provided content.

Are dollar amounts provided in the JAZZ Rule 144 rows?

Yes, numeric amounts appear adjacent to the sale rows: 1,143,010.3 and 1,118,613.32. The excerpt presents these numbers alongside the 6,000-share entries but does not label them explicitly.

Does the filing state whether Jazz receives proceeds from these sales?

The excerpt does not specify who receives proceeds or any use of proceeds. The rows list share counts, dates, and numeric amounts without an explicit proceeds recipient statement in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/01/2026 - 03:44 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001193210
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Jazz Pharmaceuticals Plc
SEC File Number	001-33500
Address of Issuer	5th Floor Waterloo Exchange Waterloo Road Dublin IRELAND D04 E5W7
Phone	353-1-634-7800
Name of Person for Whose Account the Securities are To Be Sold	Bruce C Cozadd
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 3075A Hansen Way 1st Floor Palo Alto CA 94304	6000	1219980	62738815	05/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/17/2024	Stock Option	Jazz Pharmaceuticals PLC			6000	01/17/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Bruce Cozadd 5th Floor Waterloo Exchange Waterloo Road Dublin L2 D04-E5W7	Common	04/01/2026	6000	1143010.3
Bruce Cozadd 5th Floor Waterloo Exchange Waterloo Road Dublin L2 D04-E5W7	Common	03/03/2026	6000	1118613.32

144: Remarks and Signature

Remarks
Date of Notice	05/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Bruce C Cozadd
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)